arrow
F

Fábio Pires de Souza Santos

universidad autonoma de nuevoleon
H指数:24
被引数:3,361

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Modern Strategies for Graft-Versus-Host Disease Prophylaxis on Relapse Risk in Matched-Sibling or Unrelated Donor Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Randomized Trials

现代移植物抗宿主病预防策略对匹配同胞或无关供者造血细胞移植复发风险的影响:随机试验的系统评价和荟萃分析

2026-08-010
PRE
Peripheral blood or bone marrow grafts for mismatched unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis

供者外周血或骨髓移植,用于HLA不合的无关供者,并采用移植后环磷酰胺为基础的移植物抗宿主病预防方案。

2025-10-120
PRE
MOLECULAR OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME IN A SINGLE CENTER IN LATIN AMERICA FROM 2018 TO 2023

拉丁美洲某单中心2018年至2023年骨髓增生异常综合征患者的分子结局

2025-09-010
PRE
Implementation and adoption of a web tool to support precision diagnostic and treatment decisions for patient with myelodysplastic syndromes

实施和采用网络工具以支持骨髓增生异常综合征患者的精确诊断和治疗决策

2023-04-040
PRE
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (vol 26, pg 1549, 2020)

TP53等位基因状态对骨髓增生异常综合征基因组稳定性、临床表现和预后的影响 (第26卷,1549页,2020)

2021-02-092
OAAI
Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia

逆转素通过多种细胞死亡机制在急性淋巴细胞白血病中发挥细胞毒性作用

2020-08-289
PREAI
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Tp53等位基因状态对骨髓增生异常综合征基因组稳定性、临床表现和预后的影响

2020-08-03406
OAAI
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis
LEUKEMIA
IF13.4
2019-10-1863
OAAI
Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis
2015-11-193
OAAI